“GLP-1 Receptor Agonists and Substance Use Disorders: A Public Health Opportunity With Emerging Safety Concerns”. Epidemiology, Biostatistics, and Public Health, vol. 21, no. 1, Nov. 2025, https://doi.org/10.54103/2282-0930/29800.